Cargando…

The Immunotherapy Landscape in Adrenocortical Cancer

SIMPLE SUMMARY: Adrenocortical carcinoma is a rare and life-threatening cancer originating from the adrenal glands. Although aggressive surgical interventions may cure this cancer when detected at early stages, treatments for advanced or metastatic disease are limited and often unable to shrink or c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pegna, Guillaume J., Roper, Nitin, Kaplan, Rosandra N., Bergsland, Emily, Kiseljak-Vassiliades, Katja, Habra, Mouhammed Amir, Pommier, Yves, Del Rivero, Jaydira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8199088/ https://www.ncbi.nlm.nih.gov/pubmed/34071333 http://dx.doi.org/10.3390/cancers13112660

Ejemplares similares

Preclinical Models of Adrenocortical Cancer
por: Sedlack, Andrew J. H., et al.
Publicado: (2023)

Pediatric adrenocortical carcinoma
por: Ilanchezhian, Maran, et al.
Publicado: (2022)

OR04-6 Comprehensive Profiling of the MELK Inhibitor OTSSP167's Action and Its Effect on Sensitization to Wee1 Inhibitor AZD1775 in a Spectrum of ACC Models
por: Bagby, Stacey, et al.
Publicado: (2022)

Response to Immunotherapy in Combination With Mitotane in Patients With Metastatic Adrenocortical Cancer
por: Head, Lia, et al.
Publicado: (2019)

Adjuvant therapy in adrenocortical carcinoma: prognostic factors and treatment options
por: Al-Ward, Ruaa, et al.
Publicado: (2022)

Adjuvant Therapy in Adrenocortical Carcinoma: Reflections and Future Directions
por: Bedrose, Sara, et al.
Publicado: (2020)

SAT-LB064 Mitotane Induces Autophagy: A Mechanism to Promote Chemoresistance in Adrenocortical Carcinoma
por: Tompkins, Kenneth, et al.
Publicado: (2019)

Metastatic and recurrent adrenocortical cancer is not defined by its genomic landscape
por: Fojo, Tito, et al.
Publicado: (2020)

FRI199 Severe Hypertriglyceridemia And Acute Pancreatitis In A Patient With Adrenocortical Carcinoma (ACC) Taking Mitotane
por: Cortez, Briana Noel, et al.
Publicado: (2023)

Association of Cigarette Smoking with Aberrant Methylation of the Tumor Suppressor Gene RARβ2 in Papillary Thyroid Cancer
por: Kiseljak-Vassiliades, Katja, et al.
Publicado: (2011)

Leptomeningeal Metastasis from Adrenocortical Carcinoma: A Case Report
por: Schreiber, Anna R, et al.
Publicado: (2020)

Preclinical Models of Neuroendocrine Neoplasia
por: Sedlack, Andrew J. H., et al.
Publicado: (2022)

Response to Letter to the Editor From Berruti et al: “Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients’ Survival”
por: Srougi, Victor, et al.
Publicado: (2022)

SUN-337 Anti-tumorigenic Effects Of The Maternal Leucine Zipper Kinase (MELK) Inhibitor, OTSSP167, In Pre-clinical In Vivo Models Of Adrenocortical Carcinomas (ACC)
por: KAR, ADWITIYA, et al.
Publicado: (2019)

Grade Progression and Intrapatient Tumor Heterogeneity as Potential Contributors to Resistance in Gastroenteropancreatic Neuroendocrine Tumors
por: Varghese, Diana Grace, et al.
Publicado: (2023)

SUN-348 Cabozantinib in Advanced Adrenocortical Carcinoma: Rationale and Protocol of Two Phase II Clinical Trials
por: Kroiss, Matthias, et al.
Publicado: (2019)

Endocrine and Neuroendocrine Tumors Special Issue—Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?
por: Jimenez, Camilo, et al.
Publicado: (2022)

Adjuvant platinum-based chemotherapy in radically resected adrenocortical carcinoma: a cohort study
por: Kimpel, Otilia, et al.
Publicado: (2021)

RF19 | PSUN33 Adrenocortical Carcinoma as a Rare Manifestation of Birt-Hogg-Dubé Syndrome
por: Else, Tobias, et al.
Publicado: (2022)

New Insights on the Genetics of Pheochromocytoma and Paraganglioma and Its Clinical Implications
por: Jhawar, Sakshi, et al.
Publicado: (2022)

Case Report of an Adrenocortical Carcinoma Associated With Germline CHEK2 Mutation
por: Xie, Changqing, et al.
Publicado: (2018)

Insights From Targeted Genetic Analysis of 364 Adrenocortical Carcinomas
por: Pozdeyev, Nikita, et al.
Publicado: (2021)

Active steroid hormone synthesis renders adrenocortical cells highly susceptible to type II ferroptosis induction
por: Weigand, Isabel, et al.
Publicado: (2020)

PSAT010 Severe Cholestatic Jaundice (Stauffer Syndrome) as a Rare Paraneoplastic Manifestation in Adrenocortical Carcinoma
por: Murvelashvili, Natia, et al.
Publicado: (2022)

SAT-175 Trial in Progress Interim Report: A Phase II Clinical Trial Using Single Agent Cabozantinib in Advanced Adrenocortical Carcinoma
por: Bedrose, Sara Shokry Daniel, et al.
Publicado: (2020)

SUN-211 Active Steroid Hormone Synthesis Renders Adrenocortical Cells Highly Susceptible to Type II Ferroptosis Induction
por: Weigand, Isabel, et al.
Publicado: (2020)

Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma
por: Shetty, Impana, et al.
Publicado: (2019)

Multikinase inhibitors use in differentiated thyroid carcinoma
por: Jasim, Sina, et al.
Publicado: (2014)

Relacorilant With Pembrolizumab: A Phase 1b, Open-Label Study of a Selective Glucocorticoid Receptor Modulator Combined With a Checkpoint Inhibitor for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production
por: Habra, Mouhammed Amir, et al.
Publicado: (2021)

Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET
por: Raygada, Margarita, et al.
Publicado: (2021)

Phase II clinical trial of pembrolizumab efficacy and safety in advanced adrenocortical carcinoma
por: Habra, Mouhammed Amir, et al.
Publicado: (2019)

OR08-02 In Situ Reconstruction Of Distinct Normal And Pathological Cell Populations Within The Human Adrenal Gland Using Spatial Transcriptomics
por: Rui, Fu, et al.
Publicado: (2023)

Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer
por: Laha, Dipranjan, et al.
Publicado: (2022)

FRI191 Changes In The Incidence And Geographical Distribution Of Adrenocortical Carcinoma: A Retrospective Analysis Of A State Cancer Registry
por: Brondani, Vania B, et al.
Publicado: (2023)

Genomic landscape of pediatric adrenocortical tumors
por: Pinto, Emilia M., et al.
Publicado: (2015)

Therapy Resistant Gastroenteropancreatic Neuroendocrine Tumors
por: McClellan, Kristen, et al.
Publicado: (2022)

The Role of Immunotherapy in the Treatment of Adrenocortical Carcinoma
por: Karwacka, Izabela, et al.
Publicado: (2021)

Immunotherapy failure in adrenocortical cancer: where next?
por: Cosentini, Deborah, et al.
Publicado: (2018)

Long‐term outcomes in patients with advanced adrenocortical carcinoma after image‐guided locoregional ablation or embolization
por: Mauda‐Havakuk, Michal, et al.
Publicado: (2021)

PSUN13 Transcriptional and epigenetic landscapes of adrenocortical tumors
por: Lerario, Antonio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bma04c8dgt92kmq1gimjgo99a9